Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.0030 AUD
Change Today 0.00 / 0.00%
Volume 0.0
As of 2:16 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

medivac ltd (MDV) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEDIVAC LTD (MDV)

Related News

No related news articles were found.

medivac ltd (MDV) Related Businessweek News

No Related Businessweek News Found

medivac ltd (MDV) Details

Medivac Limited develops clinical technology products for application in hospital and other medical settings in Australia and internationally. The company’s portfolio of clinical technology products include SunnyWipes, which consists of various antimicrobial hand hygiene and general cleaning products; and Diakyne, a product that identifies trace elements in body fluids using the Tracesmart technology. It also acts as an investment manager; and operates a portfolio of investments in micro-cap companies, companies at pre initial public offering stage, and companies involved in the resources sector. Medivac Limited is based in Sydney, Australia.

medivac ltd (MDV) Top Compensated Officers

Finance Manager
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Company Secretary and Executive Director
Total Annual Compensation: --
Operations Manager – Medivac Technology
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

medivac ltd (MDV) Key Developments

Medivac Limited Announces Management Changes

The Directors of Medivac Limited appointed Mr. Phillip Pryor as Chairman of the Company. Mr. Pryor served as the Chief Executive Officer at Australian Institute of Refrigeration, Air Conditioning and Heating (AIRAH). Mr. Pryor has been a Non-Executive Director of Ft8 (UK) PLC since January 2009. Current Non-Executive Director Craig Hitchings has moved into the role of Executive Director and Company Secretary and Rodger Johnston will resign as Managing Director, but continue on in the role of a Non-Executive Director. Non-Executive Director Peter Elliott has resigned as Non-Executive Director.

Medivac Limited Announces Change of Registered Office

Medivac Limited announced that its registered office and principal place of business address has changed to: Suite 6, Level 9, 66 Hunter Street SYDNEY NSW 2000.

Medivac Limited Announces Resignation of Sophie Karzis as Secretary

Medivac Limited announced that Ms. Sophie Karzis has resigned as Secretary of Medivac, effective 23 January 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDV:AU A$0.00 AUD 0.00

MDV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDV.
View Industry Companies

Industry Analysis


Industry Average

Valuation MDV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVAC LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at